NERV · Insider Trading
Minerva Neurosciences, Inc
Every open-market purchase and sale reported by NERV officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-03 | Inderjit Kaul | Director | A | +12,147 deriv. | — |
| 2026-06-05 | Inderjit Kaul | Director | A | +50,000 deriv. | — |
| 2026-06-05 | Remy Luthringer | CEO | A | +1,690,700 deriv. | — |
| 2026-06-05 | Frederick W Ahlholm | SVP, CFO and Secretary | A | +680,000 deriv. | — |
| 2026-06-05 | Hans Peter Hasler | Director | A | +50,000 deriv. | — |
| 2026-06-05 | G Jan Van Heek | Director | A | +50,000 deriv. | — |
| 2026-06-05 | Fouzia Laghrissi-Thode | Director | A | +50,000 deriv. | — |
| 2026-06-05 | David Kupfer | Director | A | +50,000 deriv. | — |
| 2026-04-22 | James Joseph O'Connor | Chief Business Officer and GC | A | +350,800 deriv. | — |
| 2026-04-01 | Inderjit Kaul | Director | A | +12,169 deriv. | — |
| 2025-12-23 | Frederick W Ahlholm | SVP, CFO and Secretary | A | +500,000 deriv. | — |
| 2025-12-23 | Inderjit Kaul | Director | A | +364,504 deriv. | — |
| 2025-12-23 | Hans Peter Hasler | Director | A | +50,000 deriv. | — |
| 2025-12-23 | Fouzia Laghrissi-Thode | Director | A | +50,000 deriv. | — |
| 2025-12-23 | Remy Luthringer | CEO | A | +2,250,000 deriv. | — |
| 2025-12-23 | David Kupfer | Director | A | +50,000 deriv. | — |
| 2025-12-23 | Geoff Race | President | A | +1,500,000 deriv. | — |
| 2025-12-23 | G Jan Van Heek | Director | A | +50,000 deriv. | — |
| 2025-11-18 | Inderjit Kaul | Director | A | +9,500 deriv. | — |
| 2024-12-06 | Frederick W Ahlholm | SVP, CFO and Secretary | A | +47,500 deriv. | — |
| 2024-12-06 | David Kupfer | Director | A | +12,500 deriv. | — |
| 2024-12-06 | G Jan Van Heek | Director | A | +12,500 deriv. | — |
| 2024-12-06 | Geoff Race | President | A | +95,000 deriv. | — |
| 2024-12-06 | Fouzia Laghrissi-Thode | Director | A | +12,500 deriv. | — |
| 2024-12-06 | Hans Peter Hasler | Director | A | +12,500 deriv. | — |
| 2024-12-06 | Remy Luthringer | CEO | A | +105,000 deriv. | — |
| 2023-10-05 | Frederick W Ahlholm | SVP, CFO and Secretary | A | +42,850 deriv. | — |
| 2023-10-05 | Remy Luthringer | CEO | A | +100,450 deriv. | — |
| 2023-10-05 | Geoff Race | President | A | +87,050 deriv. | — |
| 2023-09-29 | David Kupfer | Director | A | +12,500 deriv. | — |
| 2023-09-29 | Hans Peter Hasler | Director | A | +12,500 deriv. | — |
| 2023-09-29 | G Jan Van Heek | Director | A | +12,500 deriv. | — |
| 2023-09-29 | Fouzia Laghrissi-Thode | Director | A | +12,500 deriv. | — |
| 2023-09-29 | Jeryl L Hilleman | Director | A | +12,500 deriv. | — |
| 2023-05-02 | Geoff Race | President | MIXED | +24,905 | −$85.02K |
| 2023-05-02 | Frederick W Ahlholm | SVP, CFO and Secretary | MIXED | +16,263 | −$16.04K |
| 2023-05-02 | Remy Luthringer | CEO | MIXED | +60,683 | −$105.14K |
| 2022-12-14 | Remy Luthringer | CEO | A | +45,000 deriv. | — |
| 2022-12-14 | Frederick W Ahlholm | SVP, CFO and Secretary | A | +26,000 deriv. | — |
| 2022-12-14 | Geoff Race | President | A | +38,000 deriv. | — |
| 2022-06-28 | David Kupfer | Director | A | +2,500 deriv. | — |
| 2022-06-28 | G Jan Van Heek | Director | A | +2,500 deriv. | — |
| 2022-06-28 | Fouzia Laghrissi-Thode | Director | A | +2,500 deriv. | — |
| 2022-06-28 | Jeryl L Hilleman | Director | A | +2,500 deriv. | — |
| 2022-06-28 | William F Doyle | Director | A | +2,500 deriv. | — |
| 2022-06-28 | Hans Peter Hasler | Director | A | +2,500 deriv. | — |
| 2022-02-18 | Frederick W Ahlholm | CFO | A | +180,000 deriv. | — |
| 2022-02-18 | Remy Luthringer | CEO | A | +505,000 deriv. | — |
| 2022-02-18 | Geoff Race | President | A | +200,000 deriv. | — |
| 2021-12-03 | David Kupfer | Director | Sell | −55,635 | −$48.96K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Remy Luthringer | CEO | 184,819 | $425.08K |
| Geoff Race | President | 73,406 | $168.83K |
| David Kupfer | Director | 23,936 | $55.05K |
| Frederick W Ahlholm | SVP, CFO and Secretary | 21,098 | $48.53K |
| G Jan Van Heek | Director | 2,542 | $5.85K |
| Hans Peter Hasler | Director | 1,250 | $2.88K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the NERV quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.